Consultancy and digital solutions for pharma and biotech
Consultancy and digital solutions for pharma and biotech
The pharmaceutical and biotech industries have been put under the spotlight in an unprecedented way over the last year and this shows no sign of abating. There is increased pressure to find solutions to today’s healthcare and societal issues which will have an impact on future economies and people’s quality of life.
Atos can support you with a full range of expertise and services to enrich and streamline virtually every process in your research, production and delivery value chain, bringing you expertise combined with best in class innovation and security.
Pharmaceutical and biotech key challenges
Reduce operational costs >
Reduce operational costs
Digital innovations and technologies enable companies to optimize essential research and production to create economies of scale for further investments.
Drive productivity >
Drive productivity
Redefine production processes and adopt digital technologies increasing productivity to provide drugs faster and at a lower cost under pressure.
Improve quality and compliance >
Improve quality and compliance
Assisting the guarantee of high quality and safe drugs and vaccines produced in line with the standards of national and international regulation authorities.
Supporting pharma from molecule discovery to drug production
Research and Development >
Research and Development
From molecule to market, combine pioneering research and technological expertise to create a healthier world
Life Sciences Digital Manufacturing >
Life Sciences Digital Manufacturing
Performance and innovation to deliver the healthcare products and devices that our modern societies need
Pharma and biotech solutions
Atos OneCloud for life sciences
Streamlining processes and delivering innovation through the cloud
Cybersecurity in life sciences
Protecting highly sensitive data and securing employee access to applications
Net zero for healthcare and life sciences
Guiding your journey to net zero carbon to improve efficiency and reduce costs
Drug discovery & pre-clinical research
Clinical trials
Accelerating clinical trials and reducing costs with digital technologies
Intelligent regulatory and quality
Ensuring your processes meet quality and regulatory requirements
Digital manufacturing
Boost capacity and quality while reducing costs and time to market
Digital Twin for Pharma
Optimize operations and quality, bringing products to market faster
Digital workplace solutions
Ensuring a secure, flexible and mobile employee, staff, and member experience
Related insights
Blog
The role of digital twins in producing a COVID-19 vaccine
With the attention of the world on the search for a COVID-19 antidote, state-of-the-art technology has a vital part to play throughout the research and development lifecycle.
Video
Smart Clinical Trials
Smart Trials Platform that provides a comprehensive set of services for conducting clinical trials.
Webinar
Faster, easier and cheaper technology transfer: a new differentiator for pharma and biotech companies
Atos and Fluxa are pioneering the use of digital technologies to transform the technology transfer process and make it faster, easier and more efficient.
Talk to our experts
Harbir Sawhney
Global Portfolio Head, Life Sciences
Natalia Jiménez Lozano
Head of Atos Life Science Center of Excellence
Miles Newman
Client Relationship Manager- Healthcare & Life Sciences, Northern Europe
Why Atos for your digital journey
100+
years of delivering healthcare ICT
1k+
major healthcare providers in Europe and North America
10k+
health and life science specialists worldwide
1m+
digital transactions a day. managed by Atos
Atos recognized by Frost and Sullivan for 2021 Customer Value Leadership – Global COVID-19 Digital Vaccination Solutions Industry, Excellence in Best practices.
In 2020 Atos was ranked by Gartner #1 in EMEA and #3 worldwide in managed services and cloud infrastructure in healthcare by revenue for the second year in a row.
Atos identified as a leading provider in the HFS Top 10 Life Science services 2019 report.